U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 184

Variation
Gene
(Protein Change)
Type
(Consequence)
ConditionClassification, Review status
LOC130060335, LOC130060336
+242 more
Copy number gain
See cases
GPathogenic
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GLikely benign
ELAC2
(R811W +2 more)
Single nucleotide variant
(missense variant)
not provided
+2 more
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
not specified
+2 more
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
not provided
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
Prostate cancer, hereditary, 2
+2 more
GLikely benign
ELAC2
(A792V +2 more)
Single nucleotide variant
(missense variant)
Inborn genetic diseases
+3 more
GUncertain significance
ELAC2
(K783R +2 more)
Single nucleotide variant
(missense variant)
not provided
+1 more
GConflicting classifications of pathogenicity
ELAC2
(R781H +2 more)
Single nucleotide variant
(missense variant)
Inborn genetic diseases
+2 more
GConflicting classifications of pathogenicity
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
+1 more
GLikely benign
ELAC2
(M675fs +2 more)
Deletion
(frameshift variant)
not provided
+1 more
GPathogenic/Likely pathogenic
ELAC2
Single nucleotide variant
(synonymous variant)
not specified
+3 more
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not specified
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
+1 more
GBenign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
Prostate cancer, hereditary, 2
+3 more
GBenign
ELAC2
Single nucleotide variant
(synonymous variant)
not provided
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
+1 more
GBenign
ELAC2
Single nucleotide variant
(synonymous variant)
not specified
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
not specified
+1 more
GBenign/Likely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
(A541T +2 more)
Single nucleotide variant
(missense variant)
not specified
+3 more
GBenign/Likely benign
ELAC2
Single nucleotide variant
(synonymous variant)
not specified
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
Prostate cancer, hereditary, 2
+3 more
GBenign
ELAC2
Single nucleotide variant
(synonymous variant)
not specified
+1 more
GConflicting classifications of pathogenicity
ELAC2
Duplication
(intron variant)
not provided
GLikely benign
ELAC2
Deletion
(intron variant)
not provided
GBenign
ELAC2
Deletion
(intron variant)
not provided
GLikely benign
ELAC2
Duplication
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
not provided
+3 more
GBenign
ELAC2
(P453L +2 more)
Single nucleotide variant
(missense variant)
not provided
GLikely pathogenic
ELAC2
(E482* +2 more)
Single nucleotide variant
(nonsense)
not provided
+2 more
GConflicting classifications of pathogenicity
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
(R464W +2 more)
Single nucleotide variant
(missense variant)
not provided
+1 more
GBenign/Likely benign
ELAC2
Single nucleotide variant
(synonymous variant)
Prostate cancer, hereditary, 2
+3 more
GBenign
ELAC2
Indel
(intron variant)
Combined oxidative phosphorylation defect type 17
+2 more
GBenign/Likely benign
ELAC2
Microsatellite
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Prostate cancer, hereditary, 2
+3 more
GBenign
ELAC2
Insertion
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Deletion
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
Prostate cancer, hereditary, 2
+3 more
GBenign
ELAC2
(R427H +2 more)
Single nucleotide variant
(missense variant)
not provided
+1 more
GUncertain significance
ELAC2
(R428C +2 more)
Single nucleotide variant
(missense variant)
not provided
+1 more
GUncertain significance
ELAC2
(Y425* +2 more)
Single nucleotide variant
(nonsense)
not provided
+1 more
GPathogenic/Likely pathogenic
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Prostate cancer, hereditary, 2
+3 more
GBenign
ELAC2
(I396V +1 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
+2 more
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
+1 more
GLikely benign
ELAC2
(K384M +1 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
+1 more
GUncertain significance
ELAC2
(N379K +1 more)
Single nucleotide variant
(missense variant)
not provided
+1 more
GUncertain significance
ELAC2
(N331S +1 more)
Single nucleotide variant
(missense variant)
not provided
GUncertain significance
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Deletion
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
(R320W +1 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
+1 more
GUncertain significance
ELAC2
(V308M +1 more)
Single nucleotide variant
(missense variant)
not provided
+1 more
GUncertain significance
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
Format
Items per page
Sort by
Choose Destination